Tomorrow’s Jam Today
Featured in this month’s Master Investor Magazine. Often, a company can have an exciting product in the pipeline for years…
10 years ago
Equities
British Land at 876p – up with events in valuation terms but with some upward momentum
I have been a bull of British Land (BLND) ordinary shares because of quantitative easing - first in the UK…
10 years ago
Advanced Oncotherapy (AVO) LIGHTs up
I last looked at Advanced Oncotherapy (AVO) back in the Spreadbet Magazine days, having identified them as part of a…
10 years ago
AIM Heavyweights: ASOS and GW Pharma
By Matthew Heywood of Spreadex Trading AIM stocks is a great way to invest in smaller companies that have the…
10 years ago
Greggs (GRG): Food For Thought
There is an old saying that ridiculously overvalued shares can get even more ridiculously overvalued. Competitive markets may be perfect…
10 years ago
Barclays (BARC) – Discounting the risks?
Barclays Bank (BARC) saw a 60% fall in underlying earnings in the year to 31st December 2013, which was modestly…
10 years ago
GlaxoSmithKline (GSK) – Q1 results have Biblical flavour
The first quarter results and statement from GSK has a biblical flavour. We are exalted to raise our gaze unto…
10 years ago
Associated British Foods – a business camouflaged in sugar and Ovaltine
Technically interesting perhaps but still very highly price on near term earnings estimates. My last words on this magnificently highly…
10 years ago
Ladbrokes – the eyes of the cobra
It was a mere fifty days or so ago - yes, as little time as that – when I last…
10 years ago
BP: holed just above the waterline
BP’s first quarter results come from a rather battered company that looks (in my imagination) a bit like one of…
10 years ago